Response to vismodegib in recurrent meduloblastoma.
Rev. colomb. hematol. oncol. [Internet]. 2013 Oct. 1 [cited 2024 Dec. 22];2(3):45-51. Disponible en: https://doi.org/10.51643/22562915.353